A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05645627 · COMPLETED
Trial details
- NCT number
- NCT05645627
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2023-08-09
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.